Cunningham J J, Calles-Escandon J, Garrido F, Carr D B, Bode H H
Endocrinology. 1986 Jan;118(1):98-101. doi: 10.1210/endo-118-1-98.
Metabolic defects in obese (fa/fa) Zucker rats have previously been shown to be reversed by adrenalectomy; however, hypercorticosteronemia has not been demonstrated. We now report that the total daily excretion of corticosterone and urea nitrogen are significantly greater (P less than 0.01) in obese Zucker rats than in age-matched lean Zucker rats. This excessive excretion of corticosterone is not of autonomous adrenal origin, since dexamethasone treatment (20 micrograms/kg X day) for 2 days induced a proportionate reduction in corticosterone excretion (approximately 50%) in both obese and lean Zucker rats. Corticosterone excretion was further suppressed to levels not different from those in lean rats after 2 days of dexamethasone (40 micrograms/kg X day). Both the peak and total pituitary beta-endorphin secretion in response to an iv bolus of corticotropin-releasing factor (CRF) were diminished in obese Zuckers. The response to CRF in obese Zucker rats was dampened and superimposable on that of dexamethasone-treated lean Zucker rats, suggesting the existence of chronic hypercorticosteronemia as a component of this genetic obesity. These observations provide evidence for a compensatory alteration of the pituitary-adrenal axis. We suggest that corticosterone turnover may be increased in obese Zucker rats.
肥胖(fa/fa) Zucker大鼠的代谢缺陷先前已被证明可通过肾上腺切除术得到逆转;然而,高皮质醇血症尚未得到证实。我们现在报告,肥胖Zucker大鼠的皮质酮和尿素氮每日总排泄量显著高于(P<0.01)年龄匹配的瘦Zucker大鼠。这种皮质酮的过度排泄并非源于肾上腺自主分泌,因为地塞米松治疗(20微克/千克×天)2天可使肥胖和瘦Zucker大鼠的皮质酮排泄量成比例减少(约50%)。地塞米松(40微克/千克×天)治疗2天后,皮质酮排泄进一步被抑制至与瘦大鼠无异的水平。肥胖Zucker大鼠对静脉注射促肾上腺皮质激素释放因子(CRF)的垂体β-内啡肽分泌峰值和总量均降低。肥胖Zucker大鼠对CRF的反应减弱,且与地塞米松治疗的瘦Zucker大鼠的反应重叠,提示存在慢性高皮质醇血症是这种遗传性肥胖的一个组成部分。这些观察结果为垂体-肾上腺轴的代偿性改变提供了证据。我们认为肥胖Zucker大鼠的皮质酮周转率可能增加。